BackGreenLight Biosciences- Warrants (30/09/2027) Overview

GreenLight Biosciences- Warrants (30/09/2027) Current Cash

Latest current cash for GRNAW: $32M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$32.35M
↓ 61.13% YoYΔ $-50.87M vs prior year quarter

Peer average / median

Loading

GreenLight Biosciences- Warrants (30/09/2027) Current Cash History

Loading

GreenLight Biosciences- Warrants (30/09/2027) vs. peers: Current Cash Comparison

Loading

GreenLight Biosciences- Warrants (30/09/2027) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GreenLight Biosciences- Warrants (30/09/2027) (GRNAW) FAQ

As of the most recent data (March 2023), GRNAW shows a current cash of $32M. That compares with $83M in the prior-year period — down 61.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRNAW's current cash is now $32M (was $83M) — a 61.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GreenLight Biosciences- Warrants (30/09/2027) is outperforming or lagging.

Tracking GRNAW's current cash over time shows whether GreenLight Biosciences- Warrants (30/09/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $32M That compares with $83M in the prior-year period — down 61.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has GreenLight Biosciences- Warrants (30/09/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $32M) with ownership activity and broader fundamentals.